Liothyronine Sodium
- Product NDC
- 0093-2178
- 11-digit product format
- 000932178
- Labeler code
- 0093
- Product ID
- 0093-2178_22ed1e76-c20a-481e-bc00-2b531d14c3e4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Liothyronine Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA211510
- Marketing category
- ANDA
- Marketing start
- 2021-02-26
- Substance
- LIOTHYRONINE SODIUM
- Active strength
- 25 ug/1
- Pharmacologic classes
- Triiodothyronine [CS], l-Triiodothyronine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Liothyronine Sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LIOTHYRONINE SODIUM | 25 ug/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | GCA9VV7D2N |
| Rxcui | 903456, 903697, 903703 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0093-2178-01 | Liothyronine Sodium | 100 in 1 BOTTLE | TABLET | 100 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0093-2178 | LIOTHYRONINE SODIUM TABLET [TEVA PHARMACEUTICALS USA, INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20210227_548d684a-86f5-4e57-9844-d8cf0a84e068.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-2178-01 | 00093217801 | 100 TABLET in 1 BOTTLE (0093-2178-01) | 100 tablet | 2021-02-26 | 0000-00-00 | No | No | Current |